Wen Kin Lim is a Harding PhD Scholar at the Babraham Institute and University of Cambridge (St Catharine’s College). He became interested in longevity research during his undergraduate thesis research on signalling in stem cell regulation and ageing. He is particularly interested in how tackling ageing can be the most powerful way to achieve preventive medicine and improve modern healthcare. Wen’s current PhD research is on the mechanisms of ageing, specifically the loss of protein homeostasis and RNA oxidative damage that accumulates with age.

Baptiste's interest in longevity began at the age of 14. During high school, he pursued his passion for biology as an autodidact. He later completed a Bachelor's degree in Life Sciences at the University of Marseille, followed by a Master's degree at the École Normale Supérieure Paris-Saclay. Now a PhD student at the Babraham Institute, Baptiste focuses on understanding how replication changes in aging cells.

Hania Luniak is a biomedical engineer and stem cell biologist passionate about understanding neurodegeneration and brain aging. She’s currently doing her PhD at the University of Cambridge, where she’s diving into how RNA oxidation contributes to diseases like ALS. Using 2D and 3D stem-cell models, Hania is exploring how spinal motor neurons are affected by oxidative stress and disrupted proteostasis.

Peter is a registered medical student at the University of Cambridge, completing his pre-clinical studies at Emmanuel College. His interest in longevity science began in secondary school after encountering epigenetic theories of ageing. He is particularly interested in translating advances in longevity research to the clinic, with the goal of enhancing healthspan and improving treatment for age-related disease.

Meghana Prakash is Head of Strategic Partnerships, where she leads partnerships with industry, research, and innovation stakeholders to support dialogue on longevity science and research. With a background in technology, product strategy, and impact-driven innovation, she focuses on building meaningful collaborations that bridge research, policy, and real-world application. She has completed her MBA from University of Cambridge and is active in the deep-tech space. She is an innovative and optimistic person who specializes in developing technologies to create an impact. With over 7 years of experience working in a Metaverse startup, Meghana looks ahead to use technology to create an impact in the social sectors.

Annisa Meutia Ratri is a Jardine Scholar at the University of Cambridge (Peterhouse), where she is pursuing a PhD in Geography. Growing up in Indonesia, she developed an interest in how ageing is experienced across different communities, especially in small islands where maritime traditions shape everyday life. Her research approaches ageing not only as a biological process, but as a social and cultural journey—shaped by gender, ethnicity, migration, geography, and more-than-human relations. Through intersectional analysis, Annisa highlights voices often overlooked in global ageing debates, advocating for more inclusive understandings of what it means to age well.

Naser is a Natural Sciences undergraduate at Christ’s College, Cambridge, researching protein phase transitions. He’s spent time at Harvard Medical School developing inducible aggregation models for neurodegenerative diseases. His current focus is on aging biology as the foundational mechanism underlying protein homeostasis failure. Nas is interested in translating aging research into therapeutically viable approaches.

George Han, a PhD student at CIMR, discovered his passion for ageing and neurodegeneration research through senior home volunteering. He has since studied nanoparticle-mediated drug delivery, Alzheimer’s disease and progeria syndromes and now focuses on a rare metabolic neurological disease.

Maja’s interest in longevity started when she was undertaking a research project on stem cell therapies in multiple sclerosis at the University of Edinburgh. It was then that she explored the link between premature ageing processes and MS, and realised that ageing processes affect most, if not all diseases. Her main interest now lies at the intersection of neurodegeneration and ageing, and she is currently researching autophagy pathways in neurodegeneration as part of her PhD at Babraham Institute.

Jack Welland is the Michael House PhD Scholar at the Cambridge Institute for Medical Research (St John’s College). He utilizes both computational and structural techniques to study how enzymes interface with membranes to conduct their function. Jack's interest in ageing research is focused on how increasing healthspan may prove the most effective strategy to tackling age-related neurodegenerative diseases (e.g., Alzheimer’s).

Petya is pursuing an MPhil in Bioscience Enterprise at Cambridge, driven by her interest in alternative proteins, medical technology, and personalised holistic healthcare. She began her career as the third hire at an early-stage tech start-up, contributing to its global growth and building innovative business models, digital experiences, and conversational AI products. She enjoys developing strategies, leading multicultural teams, and driving partnerships that support meaningful growth. Outside of work, Petya stays active and curious through fitness, biohacking, music, art, fashion, and exploring new cultures.

Max is a venture capital investor, venture builder, and creator. He is heavily involved with multiple biotech, diagnostic, digital health, and AI companies across UK, Europe and Asia. He holds a PhD and EMBA from the University of Cambridge